# BIOYOND Robotics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/bioyond-robotics

- Industry: Biotechnology
- Headquarters: Shanghai, China
- Website: www.bioyond.com
- Total disclosed funding: $29M
- Latest round: Series A (Oct 25, 2024)
- Investors on record: 7

## About

Based in Shanghai, China, and established in 2021, BIOYOND Robotics is a biotechnology company that provides automation solutions for the life science field. Its team members graduated from universities, such as Peking University, the University of Hong Kong, and Zhejiang University. And its founder, Yang Tang, worked in the ABB Robotics department and served as president of ABB Robotic China R&D center. The company has cooperates with KUKA, WuXi AppTec and other companies. In October 2024, BIOYOND Robotics closed a series A3 led by new investor Panlin Capital, with participation from other returning investors Qiming Venture Partners and BioTrack Capital.

BIOYOND provides three technology platforms, including a robotic platform, an automation platform, and a data and cloud platform. Those platforms are used for small molecule drugs, biologics, cellular gene therapy, Chinese medicine, synthetic biology, histology research, clinical diagnostics and materials science.

The company generates revenue by providing a robotic platform, automation platform, and data and cloud platform.

The company will use the funds for the company's technology research and development, product development and production, market development, etc.

## Funding rounds

- Series A, Oct 25, 2024 — Qiming Venture Partners, Panlin Capital, BioTrack Capital
- Series A, Apr 3, 2023, $29M — Hong Shan, Qiming Venture Partners, Lilly Asia Ventures, China International Capital Corporation, BioTrack Capital, Shanghai Zhangjiang Technology Venture Investment Co.,Ltd.
- Angel, Jan 1, 2021 — Hong Shan

## Investors

- Hong Shan — Angel, Series A
- Qiming Venture Partners (https://capitalatlas.ai/funds/qiming-venture-partners) — Series A
- Lilly Asia Ventures (https://capitalatlas.ai/funds/lilly-asia-ventures) — Series A
- China International Capital Corporation (https://capitalatlas.ai/funds/china-international-capital-corporation) — Series A
- BioTrack Capital (https://capitalatlas.ai/funds/biotrack-capital) — Series A
- Shanghai Zhangjiang Technology Venture Investment Co.,Ltd. — Series A
- Panlin Capital (https://capitalatlas.ai/funds/panlin-capital) — Series A